Image of Safety of New Oral Anticoagulants for Patients with Chronic Kidney Disease

LITERATURE

Safety of New Oral Anticoagulants for Patients with Chronic Kidney Disease


In daily practice, chemical substances called “direct oral anticoagulants” or DOACs are more convenient
to administer when set beside vitamin K antagonists (VKA) due to improved pharmacologic properties, fewer
drug interactions and rapid onset of action. The objective of this review was to assess whether DOACs are the
alternative for VKA in subjects with mild-to-moderate chronic kidney disease (CKD).


Availability

REQJ385Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
-
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous